Clinical Trials Logo

Filter by:
NCT ID: NCT05254912 Completed - Clinical trials for Photoallergic Response

Photoallergic Potential of 6% Bemotrizinol

Start date: March 7, 2022
Phase: Phase 2
Study type: Interventional

This clinical trial will assess the photoallergic potential of BEMT (6%), compared to a vehicle control and a negative control.

NCT ID: NCT05254600 Completed - Stress Clinical Trials

RISE RCT for Nurse Leaders

RISE
Start date: March 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether RISE for Nurse Leaders has a significant impact on nurse leaders' post-traumatic growth, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.

NCT ID: NCT05254587 Completed - Cataract Clinical Trials

Accuracy of IOLMASTER 700 Total Keratometry (TK)

Start date: February 8, 2022
Phase:
Study type: Observational

This is a multicenter study to compare the accuracy of IOL calculations in post-laser vision corrected eyes that are about to undergo or have undergone cataract surgery.

NCT ID: NCT05254574 Completed - Knee Osteoarthritis Clinical Trials

Sustained Acoustic Medicine for Knee Osteoarthritis Pain

Start date: February 14, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of knee osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.

NCT ID: NCT05254483 Completed - Clinical trials for Physical Activity in Children

Web-based Physical Activity Intervention for Children

Start date: February 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a two-arm randomized controlled trial and evaluate the feasibility, acceptability, and effects on the physical and psychosocial outcomes of children in response to a web-based physical activity intervention. 80 participants aged 8-11 will be enrolled in the Madison, WI area and can expect to be on study for up to 12 weeks.

NCT ID: NCT05254470 Completed - Back Pain Clinical Trials

Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care

Start date: September 1, 2020
Phase:
Study type: Observational

The purpose of this study is to evaluate continuous ultrasound treatment with diclofenac coupling patch during routine care of musculoskeletal injuries which failed conservative treatment to better understand clinical utilization of the treatment on types of injuries, how the treatment helps patients (pain, function and quality of life), and information on healthcare provider ordering the therapy and general workflow. Low-intensity continuous ultrasound (LICUS) is a bio regenerative technology used when normal rehabilitation is insufficient, applied with a wearable device (SAM, Zetroz Systems LLC) for daily use. The treatment provides long-duration ultrasound for approximately four hours. The objective of this study is to examine the real-world outcome data on symptoms improvement and return to function using SAM during routine care.

NCT ID: NCT05254457 Completed - Clinical trials for Plantar Fibromatosis

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Start date: February 14, 2022
Phase: Phase 3
Study type: Interventional

Assess the long-term safety and efficacy of EN3835 in participants who have participated in a parent placebo-controlled study of EN3835 and assess the efficacy and safety of EN3835 in the treatment and retreatment of Plantar Fibromatosis.

NCT ID: NCT05254210 Completed - Wrinkles Clinical Trials

Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The intended use of the Potenza™ device is to collect clinical data for brow lifting and/or treatment of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

NCT ID: NCT05254080 Completed - Brain Stimulation Clinical Trials

taVNS Cold Pressor

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This study explores the use of transcutaneous auricular vagus nerve stimulation (taVNS), a new form of neuromodulation which stimulates the ear. 24 healthy subjects without a past medical or psychiatric history will be recruited to participate in a phone screen followed by 1 lab visit. During the lab visit, subjects will participate twice in a validated stress induction technique called the cold pressor test, while concurrently receiving either active or sham taVNS. The cold pressor test consists of subjects placing their feet in an ice bath for a short period of time. Researchers will measure participant's heart rate while they receive taVNS (ear stimulation) and participate in the cold pressor test. Assessments of mood, anxiety, and stress will be collected at the beginning and end of the visit.

NCT ID: NCT05253807 Completed - Clinical trials for Non-Small Cell Lung Cancer (NSCLC)

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

FIGHT-210
Start date: April 29, 2022
Phase: Phase 2
Study type: Interventional

This is an open-label, single arm study to study the safety, efficacy and tolerability of Pemigatinib when used on participants with squamous or nonsquamous NSCLC with a documented FGFR1-3 mutations or fusions/rearrangement who have progressed on prior therapies and have no available standard treatment options